Evidence map›Paper›PMID 41695098›Full record

ArticleFrontiers in physiology2026

Editorial: Spotlight on nitric oxide: integrative approaches to study NO and RNS in physiology and disease.

Erika M Palmieri, Andrew Gow

Abstract readEditorial
In one paragraph

Article in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erika M PalmieriCancer Innovation Laboratory, National Cancer Institute (NCI)-Frederick, National Institutes of Health, Frederick, MD, United States.
Andrew GowDepartment of Pharmacology & Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, United States.

Funding

WORK ORDER 126643 B539 EXPAND IC SUITE75N91019D00024 · NIAID · LEIDOS BIOMEDICAL RESEARCH, INC. · PI BRISCOE, LYNN · 2019 to 2025
$3932.6M
Electrophilic Fatty Acids Reduce Chlorine-Lung Toxicity via Inhibition of Macrophage ActivationR21ES036419 · NIEHS · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI Andrew J Gow · 2025 to 2026
$432k
NCI NIH HHS 75N91019D00024NIEHS NIH HHS R21 ES036419
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

free radical signalingimmunomodulationnitric oxideNOreactive nitrogen speciesredox biologyRNStranslational medicine

Identifiers

PMID41695098
PMCPMC12895426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.